X0306
4
2018-09-18
0
0001717452
Odonate Therapeutics, Inc.
ODT
0001178579
TANG KEVIN C
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
1
1
1
0
Chief Executive Officer
0001191935
TANG CAPITAL PARTNERS LP
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
0
0
1
0
0001232621
TANG CAPITAL MANAGEMENT LLC
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
0
0
1
0
0001495904
Lemkey John G
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Common Stock
2018-09-18
4
P
0
10000
19.3387
A
12502338
I
By LP
Common Stock
2018-09-18
4
P
0
10000
19.3366
A
12512338
I
By LP
Common Stock
2018-09-18
4
P
0
10000
19.029
A
12522338
I
By LP
Common Stock
2018-09-18
4
P
0
10000
19.2982
A
12532338
I
By LP
Common Stock
2018-09-18
4
P
0
10000
19.4161
A
12542338
I
By LP
Common Stock
2018-09-19
4
P
0
10000
19.3086
A
12552338
I
By LP
Common Stock
2018-09-19
4
P
0
2017
19.4783
A
12554355
I
By LP
Common Stock
2018-09-20
4
P
0
7983
19.7521
A
12562338
I
By LP
Common Stock
2018-09-20
4
P
0
10000
20.0788
A
12572338
I
By LP
Common Stock
2018-09-20
4
P
0
10000
20.4267
A
12582338
I
By LP
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.21 to $19.50. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 through 11 herein.
The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management,
LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of
common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority
to vote such shares. John G. Lemkey is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Operating Officer of TCM. Mr. Tang and Mr. Lemkey both have a pecuniary interest in a portion of the shares beneficially held by TCP.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.25 to $19.50.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $18.80 to $19.25.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.07 to $19.50.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.22 to $19.47.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.20 to $19.50.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.44 to $19.50.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.34 to $19.90.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $19.86 to $20.24.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.22 to $20.50.
/s/ Kevin C. Tang
2018-09-20
/s/ Kevin C. Tang, Managing Member of Tang Capital Management, LLC, General Partner
2018-09-20
/s/ Kevin C. Tang, Managing Member
2018-09-20
/s/ John G. Lemkey
2018-09-20